Cheers, tried various subscriptions, think Platts was an early one, but found it was data analysis that came up trumps ahead of source quality.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025